US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

General Pharmaceuticals: market research reports

RSS Feeds

General Pharmaceuticals market research reports and industry analysis

1  2    4    6  7  8  9  10  
Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
11/9/2012 | published by: GBI Research
... - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and ...  |  read more...
$3,500.00
Pharmaceutical Preparations Manufacturing in the UK - Industry Market Research Report
11/7/2012 | published by: IBISWorld
... those that manufacture medical impregnated wadding, gauze, bandages and dressings, and the preparation of botanical products for pharmaceutical use. This report covers the scope, size, disposition and growth of the industry including the key sensitivities ...  |  read more...
$870.00
The Digital Patient – A Snapshot of the Digital Landscape of Patients and Caregivers
11/1/2012 | published by: CBR Pharma Insights, LLC
... patients and caregivers have pre-existing expectations of the digital experience. Digital enables brands to deliver highly targeted information in a variety of forms. It creates the setting for a brand experience versus a promotional moment. ...  |  read more...
$3,900.00
Partnerships, Licensing, Investments and M&A Deals and Trends For August 2012 In Pharmaceuticals
9/30/2012 | published by: GlobalData
... and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered ...  |  read more...
$1,000.00
Global Active Pharmaceutical Ingredients Market 2011-2015
9/12/2012 | published by: Infiniti Research Limited - TechNavio
... novel formulation technologies. The Global Active Pharmaceutical Ingredient market has also been witnessing the trend of increasing outsourcing of API manufacturing to China and India. However, the stringent regulatory environment could pose a challenge to ...  |  read more...
$2,000.00
Global Active Pharmaceutical Ingredients (API) and High Potency API (HPAPI) Industry Outlook to 2016 - Shifting Focus Towards Biotechnology
9/1/2012 | published by: Ken Research
... global API industry based on the regions such as North America, Asia-Pacific and Western Europe, market segmentation by generic and innovator API and on the basis of revenue earned from pharmaceutical raw materials for own ...  |  read more...
$1,200.00
Market for Retail Health Clinics & Urgent Care Centers
9/1/2012 | published by: Marketdata Enterprises Inc.
... drugstore chains such as CVS, grocery stores, Target and Walmart, that are open 7 days a week with extended hours and no appointment needed. They now do a lot more than flu shots. As the ...  |  read more...
$2,362.50
Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales
8/16/2012 | published by: Datamonitor
... pharma-payer deals have been used not only for launch products but also for mature brands in order to drive market share in the face of branded and generic competition alike. Scope Analysis of success drivers ...  |  read more...
$1,900.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
7/20/2012 | published by: Access China Management Consulting Ltd.
... an increase of 7.08 fold over 2000 level. A series of factors, such as an increasingly ageing population, accelerating growth of urban population as well as expansion of healthcare covering urban and rural will grow ...  |  read more...
$750.00
Research Report on Chinese Medicine Intermediate Industry, 2012
7/12/2012 | published by: China Research and Intelligence Co., Ltd.
... plants can produce them, which can be applied in drug synthesis once qualified to certain levels. Medicine intermediates instead of drugs are the raw materials of drug synthesis. Pharmaceutical industry largely demands special chemicals which ...  |  read more...
$1,500.00
Research Report on Chinese Chemosynthetic Polypeptide Drug Industry, 2012
7/12/2012 | published by: China Research and Intelligence Co., Ltd.
... focus of attentions. On one hand, the indications of polypeptide drugs are in wide range and the curative effects are obvious, mainly for the application of tumor, metabolism, cardiovascular diseases, infectious diseases, etc. On the ...  |  read more...
$3,000.00
Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
6/25/2012 | published by: GBI Research
... US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits”. It analyzes the overall Supply Chain Management (SCM) scenario and provides profiles of the leading participants in the pharmaceutical supply chain in the ...  |  read more...
$3,500.00
Pharma Wholesale and Distribution Market: World Outlook 2012-2022
6/19/2012 | published by: Visiongain
... environment. It lets you discover projected revenues at overall world market, main submarket, company and national level to 2022. You see forecasts of world-level submarkets to 2022, finding potential revenue: Original-branded drugs Generic drugs. How ...  |  read more...
$2,633.00
Perspective: The Changing Face of Pharma CRM
6/19/2012 | published by: IDC
This IDC Health Insights Perspective evaluates the changing landscape of CRM and SFA in the pharmaceutical industry and discusses manufacturers' needs and challenges and the software applications most broadly utilized.  |  read more...
$1,500.00
China Medicine Production Equipment Mfg. Industry Profile - CIC3644
5/25/2012 | published by: Beijing Zeefer Consulting Ltd.
... on the medicine production equipment mfg. industry in China, a list of major 20 enterprises in the sector as well as the comparison on investment environment in top 10 hot regions. In addition, the report ...  |  read more...
$580.00
Global Pharmaceuticals, Biotechnology & Life Sciences
5/23/2012 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global pharmaceuticals, biotechnology & life sciences market. Includes market size and segmentation ...  |  read more...
$350.00
Partnerships, Licensing, Investments and M&A Deals andTrends for April 2012 in Pharmaceuticals
5/21/2012 | published by: GlobalData
... analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the ...  |  read more...
$1,000.00
Global API Market Analysis
5/1/2012 | published by: RNCOS
... to register a healthy CAGR of around 8% during 2012-2015, is supported by various key factors, such as emergence of India and China as prominent API manufacturing hub, patent expiration of blockbuster drugs and technological ...  |  read more...
$1,200.00
Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
4/20/2012 | published by: GBI Research
... Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs”, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry. The ...  |  read more...
$3,500.00
Conference Documentation: Controlled Release
3/28/2012 | published by: SMI Publishing, Ltd
... opportunities for the development of a new generation of controlled SMi proudly presents its 9th annual Controlled-Release conference to be held in London on Wednesday 28th & Thursday 29th of March 2012. This conference continues ...  |  read more...
$800.00
The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
3/19/2012 | published by: PharmaDeals Ltd
... Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication. Data and analysis of a recent major survey undertaken ...  |  read more...
$8,005.00
Understanding Regional Chinese Health Markets
3/15/2012 | published by: Espicom Healthcare Intelligence
Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data.  |  read more...
$725.00
The Next Generation of Pharmaceutical Marketing Strategies – Understanding All of the Strategic Considerations Needed in the Age of Multiple Stakeholders
3/1/2012 | published by: CBR Pharma Insights, LLC
... a period of great transformation. Lacking a crystal ball, the industry as a whole is navigating through unchartered waters. Multiple factors are driving the need for industry-wide change. One of the biggest contributors is the ...  |  read more...
$3,900.00
Pharmaceutical Contract Manufacturing
3/1/2012 | published by: Global Industry Analysts
... and Suspensions). The report provides separate comprehensive analytics for the USA, Canada, Japan, Europe, Asia-Pacific and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic ...  |  read more...
$4,500.00
Patient Adherence and Compliance: Improving Outcomes through Patient Engagement Programs
3/1/2012 | published by: Cutting Edge Information
... in driving desired outcomes. In answer, companies show new determination to create patient-centric initiatives that will supplant the traditional, formulaic approaches of the past. Dedicated patient engagement teams are rising in prominence, and programs focused ...  |  read more...
$7,695.00
1  2    4    6  7  8  9  10  
 
Our Clients